Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Tolcapone Patent Expiration

Tolcapone is Used for managing symptoms of Parkinson's disease. It was first introduced by Bausch Health Us Llc in its drug Tasmar on Jan 29, 1998. 5 different companies have introduced drugs containing Tolcapone.


Tolcapone Patents

Given below is the list of patents protecting Tolcapone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Tasmar US5476875 Catechol derivatives Dec 19, 2012

(Expired)

 Bausch


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Tolcapone Generics

Several generic applications have been filed for Tolcapone. The first generic version for Tolcapone was by Endo Operations Ltd and was approved on Mar 26, 2015. And the latest generic version is by Alvogen Inc and was approved on Jul 29, 2020.

Given below is the list of companies who have filed for Tolcapone generic.


1. DR REDDYS LABS SA

Dr Reddys Laboratories Sa has filed for 1 generic for Tolcapone. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Discontinued ORAL N/A Aug 1, 2019


2. NOVAST LABS

Novast Laboratories Ltd has filed for 1 generic for Tolcapone. Given below are the details of the strengths of this generic introduced by Novast Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Prescription ORAL AB Aug 7, 2018


3. ALVOGEN

Alvogen Inc has filed for 1 generic for Tolcapone. Given below are the details of the strengths of this generic introduced by Alvogen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Discontinued ORAL N/A Jul 29, 2020


4. ENDO OPERATIONS

Endo Operations Ltd has filed for 1 generic for Tolcapone. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Discontinued ORAL N/A Mar 26, 2015